Recurrence prediction in clear cell renal cell carcinoma using machine learning of quantitative nuclear features

Author:

Matsubara Shuya,Saito Akira,Tokuyama Naoto,Muraoka Ryu,Hashimoto Takeshi,Satake Naoya,Nagao Toshitaka,Kuroda Masahiko,Ohno Yoshio

Abstract

AbstractThe recurrence of non-metastatic renal cell carcinoma (RCC) may occur early or late after surgery. This study aimed to develop a recurrence prediction machine learning model based on quantitative nuclear morphologic features of clear cell RCC (ccRCC). We investigated 131 ccRCC patients who underwent nephrectomy (T1-3N0M0). Forty had recurrence within 5 years and 22 between 5 and 10 years; thirty-seven were recurrence-free during 5–10 years and 32 were for more than 10 years. We extracted nuclear features from regions of interest (ROIs) using a digital pathology technique and used them to train 5- and 10-year Support Vector Machine models for recurrence prediction. The models predicted recurrence at 5/10 years after surgery with accuracies of 86.4%/74.1% for each ROI and 100%/100% for each case, respectively. By combining the two models, the accuracy of the recurrence prediction within 5 years was 100%. However, recurrence between 5 and 10 years was correctly predicted for only 5 of the 12 test cases. The machine learning models showed good accuracy for recurrence prediction within 5 years after surgery and may be useful for the design of follow-up protocols and patient selection for adjuvant therapy.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Reference19 articles.

1. Egger, S. E. et al. Renal cell carcinoma recurrence after nephrectomy for localized disease: Predicting from time of recurrence. J. Clin. Oncol. 24, 3101–3106 (2006).

2. Richards, K. A. & Abel, E. J. Surveillance following surgery for nonmetastatic renal cell carcinoma. Curr. Opin. Urol. 26, 432–438 (2016).

3. Campbell, S. C. et al. Renal mass and localized renal cancer: Evaluation, management, and follow-up: AUA guideline. J. Urol. 206, 209–218 (2021).

4. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Kidney Cancer, version 2. https://www.nccn.org/professionals/physician_gls/pdf/kidney.pdf, (2023).

5. Ljungberg, B. et al. European Association of Urology guidelines on renal cell carcinoma: the 2022 update. Eur. Urol. S0302 2838, 01676–01671 (2022). Online ahead of print.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3